摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N1-(2,4-硝基苯基)-1,2-乙二胺 | 28767-75-1

中文名称
N1-(2,4-硝基苯基)-1,2-乙二胺
中文别名
N1-(2,4-二硝基苯基)乙烷-1,2-二胺
英文名称
N-(2,4-dinitrophenyl)ethylenediamine
英文别名
2-amino-1-(N-2,4-dinitrophenyl)ethylamine;N1-(2,4-dinitrophenyl)ethane-1,2-diamine;N'-(2,4-dinitrophenyl)ethane-1,2-diamine;N’-(2,4-dinitrophenyl)ethane-1,2-diamine;1-(2-Amino-ethylamino)-2,4-dinitro-benzol;N-(2,4-Dinitrophenyl)-ethylendiamin;N-(2-Aminoethyl)-2,4-dinitro-anilin;N-Dinitrophenylethylendiamin;EdDnp;N-(2,4-Dinitro-phenyl)-aethylendiamin;N-1-(2,4-dinitrophenyl)-1,2-ethanediamine;N-(2,4-dinitrophenyl)-1,2-diaminoethane;N-(2-aminoethyl)-2,4-dinitroaniline
N1-(2,4-硝基苯基)-1,2-乙二胺化学式
CAS
28767-75-1
化学式
C8H10N4O4
mdl
MFCD00459297
分子量
226.192
InChiKey
AIUKPEQJKQUQKZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    84-85 °C
  • 沸点:
    429.6±45.0 °C(Predicted)
  • 密度:
    1.480±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    130
  • 氢给体数:
    2
  • 氢受体数:
    6

安全信息

  • 海关编码:
    2921590090

SDS

SDS:25bc9afbabd3ddf9c5df1c6913c4c994
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: N1-(2,4-Dinitrophenyl)ethane-1,2-diamine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: N1-(2,4-Dinitrophenyl)ethane-1,2-diamine
CAS number: 28767-75-1

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H10N4O4
Molecular weight: 226.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(3-amino-4-formylphenoxy)-butanoate lithiumN1-(2,4-硝基苯基)-1,2-乙二胺 在 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 4-(3-amino-4-formylphenoxy)-N-(2-(2,4-dinitrophenylamino)ethyl)butanamide
    参考文献:
    名称:
    [EN] BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIFIC PROTEIN MODIFICATIONS VIA CHEMICAL DERIVATIZATION OF PYRROLINE-CARBOXY-LYSINE AND PYRROLYSINE RESIDUES
    [FR] PYRROLINE-CARBOXY-LYSINE PRODUITE PAR BIOSYNTHÈSE ET MODIFICATIONS DE PROTÉINES SPÉCIFIQUES DE SITE OBTENUES PAR UNE DÉRIVATISATION CHIMIQUE DE PYRROLINE-CARBOXY-LYSINE ET DE RÉSIDUS DE PYRROLYSINE
    摘要:
    本文披露了吡咯酮羧基赖氨酸(PCL),一种吡咯赖氨酸类似物,它是一种天然的、生物合成产生的氨基酸,以及生物合成生成PCL的方法。本文还披露了含有PCL的蛋白质、多肽和肽以及将PCL纳入这些蛋白质、多肽和肽中的方法。本文还披露了具有PCL或吡咯赖氨酸的蛋白质、多肽和肽的特定位点衍生化。本文还披露了具有PCL或吡咯赖氨酸的蛋白质、多肽和肽的交联。
    公开号:
    WO2010048582A1
  • 作为产物:
    描述:
    1,1-Dimethylethyl N-[2-[(2,4-dinitrophenyl)amino]ethyl]carbamate三氟乙酸 作用下, 以 二氯甲烷 为溶剂, 反应 0.5h, 以95%的产率得到N1-(2,4-硝基苯基)-1,2-乙二胺
    参考文献:
    名称:
    HAPTENS, HAPTEN CONJUGATES, COMPOSITIONS THEREOF AND METHOD FOR THEIR PREPARATION AND USE
    摘要:
    公开号:
    EP2078197B1
  • 作为试剂:
    描述:
    rac-1,2-Di-O-hexadecylglycero-3-phosphatidsaeure-2'-bromethylesterN1-(2,4-硝基苯基)-1,2-乙二胺 作用下, 以 氯仿异丙醇乙腈 为溶剂, 生成 phosphoric acid 2,3-bis-hexadecyloxy-propyl ester 2-hydroxy-ethyl ester
    参考文献:
    名称:
    Nuhn; Rueger; Kertscher, Pharmazie, 1978, vol. 33, # 4, p. 181 - 183
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • A New Leaving Group in Nucleophilic Aromatic Substitution Reactions (S<sub>N</sub>Ar)
    作者:Mehdi Bakavoli、Mehdi Pordel、Mohammad Rahimizadeh、Pooneh Jahandari
    DOI:10.3184/030823408x338693
    日期:2008.8
    Nucleophilic aromatic substitution of a 2,4-dinitrophenyl substituted pyrazole 1 with primary amines leads to substitution of the pyrazolo substituent. In these nucleophilic aromatic substitution reactions (SNAr), 5-amino-1H-4-pyrazolecarbonitrile (3) acts as a new leaving group.
    2,4-二硝基苯基取代的吡唑 1 与伯胺的亲核芳族取代导致吡唑基取代基的取代。在这些亲核芳香取代反应 (SNAr) 中,5-氨基-1H-4-吡唑甲腈 (3) 作为新的离去基团。
  • [EN] ISATOIC ANHYDRIDE DERIVATIVES AND APPLICATIONS THEREOF<br/>[FR] DÉRIVÉS D'ANHYDRIDE ISATOÏQUE ET LEURS APPLICATIONS
    申请人:UNIV NORTH CAROLINA
    公开号:WO2015163952A1
    公开(公告)日:2015-10-29
    Isatoic anhydride derivatives having an N-substituent which includes a quaternary ammonium group are useful for labeling and/or functionalizing a target material and/or for coupling materials together. The isatoic anhydride derivatives of the present disclosure can be advantageously water soluble, easily prepared and purified. Isatoic anhydride derivatives useful in the present disclosure preferably have at least one chemically reactive group or at least one binding group or at least one detectable label. Anthranilate derivatives made from the isatoic anhydrides derivatives or otherwise and kits including the isatoic anhydride derivatives are also disclosed.
    异烟酰亚胺衍生物具有包括季铵基团的N-取代基,可用于标记和/或功能化目标材料和/或将材料耦合在一起。本公开的异烟酰亚胺衍生物可以具有优势的水溶性,易于制备和纯化。本公开中有用的异烟酰亚胺衍生物最好至少具有一个化学反应性基团或至少一个结合基团或至少一个可检测标记。从异烟酰亚胺衍生物制备的邻氨基苯甲酸酯衍生物或其他衍生物以及包括异烟酰亚胺衍生物的试剂盒也被公开。
  • [EN] LINKERS FOR ANTIBODY DRUG CONJUGATES<br/>[FR] LIEURS POUR CONJUGUÉS ANTICORPS-MÉDICAMENT
    申请人:UNIV TEXAS
    公开号:WO2018218004A1
    公开(公告)日:2018-11-29
    In one aspect, the present disclosure provides compounds of the formula (I): wherein the variables are as defined herein. In another aspect, the present disclosure provides compounds of the formula (V): wherein the variables are as defined herein. In another aspect, the present disclosure also provides methods of preparing the compounds disclosed herein. In another aspect, the present disclosure provides antibody drug conjugates comprising compounds of the present disclosure. In another aspect, the present disclosure also provides pharmaceutical compositions and methods of use of the compounds and anti-body drug conjugates disclosed herein.
    一方面,本公开提供了通式(I)的化合物:其中变量如本文所定义。另一方面,本公开提供了通式(V)的化合物:其中变量如本文所定义。另一方面,本公开还提供了制备本文所述化合物的方法。另一方面,本公开提供了包含本公开化合物的抗体药物偶联物。另一方面,本公开还提供了本文所述化合物和抗体药物偶联物的药物组合物及其使用方法。
  • Enzymatic conjugation using branched linkers for constructing homogeneous antibody–drug conjugates with high potency
    作者:Yasuaki Anami、Wei Xiong、Xun Gui、Mi Deng、Cheng Cheng Zhang、Ningyan Zhang、Zhiqiang An、Kyoji Tsuchikama
    DOI:10.1039/c7ob01027c
    日期:——

    An efficient enzymatic method using branched linkers was developed for the construction of potent homogeneous antibody–drug conjugates.

    开发了一种使用分支连接体的有效酶促方法,用于构建强效的均质抗体-药物偶联物。
  • Effect of Substituent on Regioselectivity and Reaction Mechanism in Aminolysis of 2,4-Dinitrophenyl X-Substituted Benzenesulfonates
    作者:Ik-Hwan Um、Jin-Young Hong、Jin-Ah Seok
    DOI:10.1021/jo048227q
    日期:2005.2.1
    a kinetic study for the nucleophilic substitution reactions of 2,4-dinitrophenyl X-substituted benzensulfonates (X = 4-MeO, 1a, and X = 4-NO2, 1c) with a series of primary amines in 80 mol % H2O/20 mol % DMSO at 25.0 °C. The reactions proceed through S−O and C−O bond fission pathways competitively. The fraction of the S−O bond fission increases as the attaching amine becomes more basic and the substituent
    我们对的2,4-二硝基苯基X取代的benzensulfonates亲核取代反应的动力学研究报告(X = 4-的MeO,1A,和X = 4-NO 2,1C),在80摩尔%一系列伯胺的在25.0°C下,H 2 O / 20 mol%DMSO。反应通过S-O和C-O键裂变途径竞争地进行。S-O键裂变的分数随连接胺变得更碱性和取代基X从4-MeO变为4-NO 2而增加,表明区域选择性是由取代基X的电子性质以及胺的碱度决定的。已建议S-O键裂变通过加成中间体进行,其中速率确定步骤(RDS)的变化为p K a °= 8.9±0.1。取代基X的电子性质影响k N S - O和k 1值,但不影响k 2 / k - 1比和p K a°值明显。通过供电子取代基和亲电子中心之间的共振相互作用,稳定基态(GS)的原因是1a的反应性比1c降低。C-O键裂变的二阶速率常数与取代基X的电子性质不相关。距离效应和反应机理的性质被认为是造成这种不相关的原因。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐